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Carbon nanotubes are capable of penetrating the cell membrane and are widely considered as potential carriers
for gene or drug delivery. Because the C-C and C=C bonds in carbon nanotubes are nonpolar, functionalization is
required for carbon nanotubes to interact with genes or drugs as well as to improve their biocompatibility. In
this study, polyethylenimine (PEI)-functionalized single-wall (PEI-NH-SWNTs) and multiwall carbon nanotubes
(PEI-NH-MWNTs) were produced by direct amination method. PEI functionalization increased the positive charge
on the surface of SWNTs and MWNTs, allowing carbon nanotubes to interact electrostatically with the negatively
charged small interfering RNAs (siRNAs) and to serve as nonviral gene delivery reagents. PEI-NH-MWNTs and
PEI-NH-SWNTs had a better solubility in water than pristine carbon nanotubes, and further removal of large
aggregates by centrifugation produced a stable suspension of reduced particle size and improved homogeneity
and dispersity. The amount of grafted PEI estimated by thermogravimetric analysis was 5.08% (w/w) and 5.28%
(w/w) for PEI-NH-SWNTs and PEI-NH-MWNTs, respectively. For the assessment of cytotoxicity, various
concentrations of PEI-NH-SWNTs and PEI-NH-MWNTs were incubated with human cervical cancer cells, HeLa-S3,
for 48 h. PEI-NH-SWNTs and PEI-NH-MWNTs induced cell deaths in a dose-dependent manner but were less
cytotoxic compared to pure PEI. As determined by electrophoretic mobility shift assay, siRNAs directed against
glyceraldehyde-3-phosphate dehydrogenase (siGAPDH) were completely associated with PEI-NH-SWNTs or
PEI-NH-MWNTs at a PEI-NH-SWNT/siGAPDH or PEI-NH-MWNT/siGAPDH mass ratio of 80:1 or 160:1, respectively.
Furthermore, PEI-NH-SWNTs and PEI-NH-MWNTs successfully delivered siGAPDH into HeLa-S3 cells at PEI-NH-SWNT/
siGAPDH and PEI-NH-MWNT/siGAPDH mass ratios of 1:1 to 20:1, resulting in suppression of the mRNA level of GAPDH
to an extent similar to that of DharmaFECT, a common transfection reagent for siRNAs. Our results indicate that the
PEI-NH-SWNTs and PEI-NH-MWNTs produced in this study are capable of delivering siRNAs into HeLa-S3 cells to
suppress gene expression and may therefore be considered as novel nonviral gene delivery reagents.
Keywords: SWNTs, MWNTs, PEI, Small interfering RNA, Gene deliveryBackground
Carbon nanotubes (CNTs) are cylindrical structures
formed by graphite sheets with a diameter in the nano-
meter range and tens to hundreds of micrometers in
length [1]. They can be categorized into single-wall carbon
nanotubes (SWNTs) and multiwall carbon nanotubes
(MWNTs), according to the number of concentric layers
of graphite sheets.* Correspondence: mjlee@mail.cjcu.edu.tw
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in any medium, provided the original work is pCarbon nanotubes are being extensively studied as car-
riers for gene or drug delivery [2-5]. In order to provide
functional groups for the binding of plasmid DNAs,
small interfering RNAs (siRNAs), or chemical compounds
and to reduce the potential toxicity of pristine carbon
nanotubes, functionalization of carbon nanotubes is ne-
cessary for their biomedical applications [6-10]. After
complexed with nucleotides or chemicals through either
covalent or noncovalent binding, functionalized carbon
nanotubes may then enter cells by endocytosis [3,11,12] or
by penetrating directly through the cell membrane
[13-15].n Open Access article distributed under the terms of the Creative Commons
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roperly cited.
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posed to viral transfection which applies viral vectors to
achieve high transfection efficiency, carbon nanotubes
are often functionalized with cationic molecules or poly-
mers in order to interact electrostatically with negatively
charged siRNAs or plasmid DNAs [7,9,16-19]. SWNTs
and MWNTs chemically modified with amino groups
were capable of delivering plasmid DNAs into A549,
HeLa, and CHO cell lines [18,19]. MWNTs functional-
ized with polycationic dendron may enhance siRNA de-
livery and gene silencing in vitro [9]. Furthermore,
positively charged SWNTs in complex with telomerase
reverse transcriptase siRNAs were shown to suppress
tumor growth in animal studies [17]. Intratumoral ad-
ministration of cytotoxic siRNAs delivered by amino-
functionalized MWNTs successfully suppressed tumor
volume in animal models of human lung cancer [20].
Polyethylenimine (PEI), a cationic polymer synthesized
in linear or branched form with various molecular
weights, is used in several studies to provide a high
density of cations on the surface of carbon nanotubes
[21,22]. It was shown that PEI-grafted MWNTs improve
the expression of plasmid DNA in human embryonic
kidney (HEK 293) and human lung epithelial (A549)
cells [22,23]. Shortened MWNTs of 200 nm in length
covalently modified with branched PEI of low molecular
weight (600 Da) deliver siRNAs with higher efficacy than
a lipid vehicle [21]. Successful delivery of siRNA to hu-
man prostate cancer PC-3 cells by PEI-functionalized
SWNTs was also reported [24]. Moreover, PEI-modified
SWNTs were shown to provide the substrate for neurite
outgrowth and branching [25].
Despite extensive applications, PEI, itself a reagent for
nonviral transfection, is cytotoxic, and chemical modifi-
cation of PEI is required to improve its application as a
transfection reagent [23,26,27]. It is therefore expected
that functionalization of carbon nanotubes with PEI
would not only increase their biocompatibility but also
reduce the toxicity of PEI. Nevertheless, contradictory
conclusions on the toxicity and transfection efficiency of
PEI-functionalized carbon nanotubes compared to pure
PEI were presented in the literature [21,23,24,28]. In this
study, SWNTs and MWNTs were functionalized with
PEI for the delivery of siRNAs. The properties and effi-
ciencies of PEI-functionalized SWNTs and MWNTs as
nonviral transfection reagents were compared, and
whether the functionalization procedure reduces the
cytotoxicity of PEI was discussed.
Methods
Materials
SWNTs of 2 to 10 nm in diameter were purchased from
Sigma-Aldrich, St. Louis, MO, USA. MWNTs of 20 to
40 nm in diameter were produced by SeedchemCompany, Melbourne, Australia. Branched PEI with an
average MW of approximately 25,000 and an average Mn
of approximately 10,000 was manufactured by Sigma-
Aldrich.
PEI functionalization of carbon nanotubes
Carbon nanotubes were covalently modified with PEI by
following the direct amination procedure in the litera-
ture [29,30]. SWNTs or MWNTs (500 mg) were mixed
with 2.5 g PEI in 50 ml dimethylformamide. The mixture
was sonicated for 30 min and stirred at 50°C for 3 days,
followed by filtration through a 0.2-μm nylon membrane
(Millipore Co., Billerica, MA, USA). The resulting PEI-
functionalized carbon nanotubes (PEI-NH-CNTs) were
washed successively with 1 M HCl, 1 M NaOH, double-
distilled water (ddH2O), and methanol, and dried under
vacuum. PEI-NH-CNTs were then resuspended in
ddH2O at a concentration of 1 mg/ml, sonicated for 15
min, and centrifuged at 3,000 rpm for 30 min. The
supernatant was stored at 4°C and used in the following
studies.
Characterization of PEI-NH-CNTs
The difference in morphology between pristine and PEI-
functionalized carbon nanotubes was examined by trans-
mission electron microscopy (TEM; 2000FX, JEOL Ltd.,
Akishima, Tokyo, Japan) and scanning electron micros-
copy (SEM; JSM-6500F). Fourier transform infrared
(FTIR) spectra of pristine and PEI-functionalized carbon
nanotubes were obtained with a PerkinElmer (Branford,
CT, USA) Spectrum 100 FTIR spectrometer. The amount
of grafted PEI in PEI-NH-CNTs was determined by
thermogravimetric analysis (TGA) using a PerkinElmer
Pyris 1 TGA instrument under nitrogen atmosphere over
a temperature range from 50°C to 800°C at a heating rate
of 10°C/min. The particle size and zeta potential of PEI-
NH-CNTs were determined by dynamic light scattering
using Zetasizer Nano ZS system (Malvern Instruments,
Worcestershire, UK).
Electrophoretic mobility shift assay
Dharmacon siGENOME GAPD control siRNA (glyceral-
dehyde 3-phosphate dehydrogenase siRNA (siGAPDH))
was purchased from Thermo Fisher Scientific, Waltham,
MA, USA. The PEI-NH-CNT/siGAPDH complex was
formed by incubating 0 to 80 μg of PEI-NH-CNTs with
0.5 μg siGAPDH at various mass ratios (0:1 to 160:1) in
serum-free RPMI-1640 medium on ice for 1 h. The
complex was then mixed with SYBR Green I and re-
solved by 1% agarose gel. The gel was run for 45 min at
100 V and then photographed under ultraviolet light
using the Gel Catcher Model 1500 imaging system
(Taiwan Green Version Technology Ltd., New Taipei
City, Taiwan).
Figure 1 Suspension of PEI-NH-SWNTs and PEI-NH-MWNTs in water. PEI-NH-SWNTs (A) and PEI-NH-MWNTs (B) were solubilized in ddH2O at
a concentration of 1 mg/ml and sonicated for 15 min (left images). Large aggregates were removed by centrifugation at 3,000 rpm for 30 min to
obtain a more homogeneous suspension (right images).
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Human cervical cancer cell line HeLa-S3 (ATCC CCL-2.2)
was purchased from the Bioresource Collection and Re-
search Center, Food Industry Research and Development
Institute, Hsinchu, Taiwan. HeLa-S3 cells were cultured at
37°C with 5% CO2 in Gibco Ham's F-12K medium (Life
Technologies, Carlsbad, CA, USA) supplemented with
10% Gibco Qualified Fetal Bovine Serum (LifeFigure 2 TEM images of pristine and PEI-functionalized carbon nanot
(C) was compared with that of PEI-NH-SWNTs (B) and PEI-NH-MWNTs (D) bTechnologies), 100 U/ml penicillin and 100 μg/mL strepto-
mycin. The medium was refreshed every 3 to 4 days.
Cell viability assay
Cell viability was determined by observation under phase
contrast microscopy as well as by the ability of viable cells
to reduce the yellow 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT; Sigma-Aldrich) toubes. The surface morphology of pristine SWNTs (A) and MWNTs
y a JEOL 2000FX TEM. Bar 20 nm.
Figure 3 SEM images of pristine and PEI-functionalized carbon nanotubes. The surface morphology of pristine SWNTs (A) and MWNTs (C)
was compared with that of PEI-NH-SWNTs (B) and PEI-NH-MWNTs (D) by a JSM-6500F SEM. Bar 100 nm.
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seeded at 5 × 104 cells/well in 24-well plates. After 48 h,
cells were treated with 0 to 100 μg/ml of PEI-NH-CNTs
in F-12K medium for another 48 h. Cells were fixed with
4% (w/v) paraformaldehyde for microscope observation.
For MTT assay, cells were incubated in freshly prepared 1
mg/ml of MTT in PBS for 2 h. After removal of the MTT
solution, dimethyl sulfoxide was added to dissolve the pur-
ple MTT formazan crystals. The absorbance of the
resulting solution was quantified spectrophotometrically
at 570 nm, using a reference wavelength of 630 nm.
siRNA transfection
HeLa-S3 cells were seeded at 2 × 105 cells/well in six-
well plates. After 24 h, PEI-NH-CNTs (0.5 to 10 μg)
was complexed with siGAPDH (0.5 μg) at various PEI-
NH-CNT/siGAPDH mass ratios (1:1 to 20:1) in serum-
free RPMI-1640 medium on ice for 1 h and then incu-
bated with HeLa-S3 cells for 48 h. The final siGAPDH
concentration was 30 nM. To serve as positive control, 0.5
μg siGAPDH was transfected by DharmaFECT Transfec-
tion Reagent (Thermo Fisher Scientific) according to the
manufacturer's instructions.
Real-time polymerase chain reaction
Total RNA was isolated from HeLa-S3 cells by TrizolW
Reagent (Life Technologies), and reverse transcription
was carried out using the Applied Biosystems High Cap-
acity cDNA Reverse Transcription Kit (Life Technolo-
gies) according to the manufacturer's instructions. ThecDNA was diluted to a final concentration of approxi-
mately 1 ng/μl and reacted with gene-specific primer
pairs and Applied Biosystems SYBR® Green PCR Master
Mix (Life Technologies) according to the manufacturer's
protocol. The primer sequences for GAPDH (NM_002046)
and β-actin (NM_001101) were designed by Origene
(Rockville, MD, USA). Primer specificity was confirmed
by Primer-BLAST developed at NCBI, and primer PCR
efficiency was validated to be close to 100%. Genes
of interest were detected and amplified by Applied
Biosystems 7300 Real-Time PCR System (Life Tech-
nologies) with the following conditions: 2 min at 50°C,
10 min at 95°C, and 40 cycles of amplification at 95°C
for 15 s and 60°C for 1 min, followed by melting curve
analysis. Amplicons were visualized with electrophoresis
on a 1.4% agarose gel to ensure the presence of a single
product. The mRNA level of each gene was analyzed by
the Applied Biosystems Sequence Detection Software
V1.2 (Life Technologies) and normalized to that of
GAPDH. Relative gene expression was calculated by the
comparative Ct (2−ΔΔct) method [31] and expressed as
fold changes (x-fold) relative to the control.Statistical analysis
Statistical analysis was performed on data from at least
three independent experiments. Significant difference
relative to the control was tested using Student's t test.
Levels of significance of p < 0.05 and 0.01 were accepted
as significant and highly significant, respectively.
Figure 4 FTIR spectra of pristine and PEI-functionalized carbon
nanotubes. Pristine and PEI-functionalized carbon nanotubes were
analyzed by a PerkinElmer Spectrum 100 FTIR spectrometer, and the
spectra were compared with that of pure PEI.




PEI functionalization remarkably increased the degree of
dispersibility of SWNTs and MWNTs. After being dis-
persed in ddH2O at 1 mg/ml and sonicated for 15 min,
PEI-NH-MWNTs and PEI-NH-SWNTs can be solubi-
lized in water and maintained in suspension form for
over 6 months without further sonication (left images,
Figure 1A, B). Because agglomeration of carbon nanotubes
as a result of van der Waals' interaction tends to increase
cytotoxicity [32,33], PEI-NH-CNTs were subjected to
centrifugation to remove large aggregates, and thesupernatant gave a more homogeneous solution of
PEI-NH-CNTs for the following studies (right images,
Figure 1A, B).
Morphology of PEI-NH-CNTs
The morphology of PEI-NH-CNTs compared to pristine
CNTs was studied by SEM and TEM. The increase in
wall thickness of PEI-NH-MWNTs compared to pristine
MWNTs suggests that PEI was coated on the surface of
PEI-NH-MWNTs (Figures 2C, D and 3C, D). On the
other hand, the aggregates originally present in pristine
SWNTs were considered as amorphous carbon (Figure 3A),
but the dramatic increase in agglomerate structures on the
surface of PEI-NH-SWNTs resulted from PEI modification
(Figures 2A, B and 3A, B).
FTIR spectroscopy of PEI-NH-CNTs
Binding of PEI to SWNTs or MWNTs was analyzed by
FTIR spectroscopy. The characteristic peak at 3,360 cm−1
was assigned to N-H of PEI, which was present in PEI-
NH-SWNTs and PEI-NH-MWNTs, but not in pristine
SWNTs or MWNTs (Figure 4). The two major peaks at
2,990 and 2,930 cm−1 in pristine SWNTs and MWNTs
were contributed by sp2 and sp3 carbon atoms, respect-
ively [34], and were shifted to 2,920 and 2,850 cm−1 in
PEI-NH-SWNTs and PEI-NH-MWNTs. Finally, the band
at 1,650 cm−1 in the spectra of PEI-NH-SWNTs and PEI-
NH-MWNTs resulted from the bending of primary amine
groups (-NH2), which was incorporated into a broad band
at 1,580 cm−1 in PEI.
PEI content of PEI-NH-CNTs
The amount of PEI introduced to PEI-NH-CNTs during
the functionalization procedure was quantified by TGA.
Pure PEI degraded nearly completely at around 420°C
(Figure 5). Pristine MWNTs were thermally stable up to
approximately 600°C while SWNTs were relatively un-
stable, and weight loss was observed at temperatures
over 450°C (Figure 5). The additional weight loss of PEI-
NH-SWNTs and PEI-NH-MWNTs at 420°C compared
to pristine carbon nanotubes was correlated directly to
the mass of PEI conjugated on PEI-NH-CNTs. Conse-
quently, the mass attributed to PEI functionalization in
PEI-NH-SWNTs and PEI-NH-MWNTs was 5.08% (w/w)
and 5.28% (w/w), respectively.
Particle size of PEI-NH-CNTs
In order to deliver siRNAs into mammalian cells, PEI-
NH-CNTs must penetrate the cell membrane. The
particle size of PEI-NH-CNTs may therefore be an im-
portant factor in determining transfection efficiency.
The particle size of 5 to 100 μg/ml PEI-NH-SWNTs and
PEI-NH-MWNTs before and after removal of large ag-
gregates through centrifugation was analyzed by
Figure 5 TGA of pristine and PEI-functionalized carbon nanotubes. The amount of PEI introduced to PEI-NH-SWNTs (A) or PEI-NH-MWNTs
(B) during the functionalization procedure was quantified by the additional weight loss of PEI-NH-SWNTs and PEI-NH-MWNTs at 420°C compared
to pristine carbon nanotubes.
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scattering is usually applied to determine the diameter dis-
tribution of spherical particles, it also facilitates the under-
standing of size distribution of dispersed carbon nanotubes
[35-38]. Prior to centrifugation, the average particle size of
5 μg/ml PEI-NH-SWNTs and PEI-NH-MWNTs was the
highest among the concentrations tested, due possibly
to the inhomogeneous nature of the suspension. After
centrifugation, the average particle size of 5 to 100 μg/
ml PEI-NH-SWNTs and PEI-NH-MWNTs in the
supernatant was 229 ± 8 to 291 ± 34 and 287 ± 8 toFigure 6 Average particle size of PEI-NH-SWNTs and PEI-NH-MWNTs b
50, and 100 μg/ml of PEI-NH-SWNTs (A) or PEI-NH-MWNTs (B) before and a
by dynamic light scattering. Before centrifugation, PEI-NH-SWNTs or PEI-NH
sonicated for 15 min; after centrifugation, PEI-NH-SWNTs or PEI-NH-MWNTs
Error bars represent standard deviations (n ≥ 3). *p < 0.05 and **p < 0.01 c
concentration before centrifugation.433 ± 102 nm, which were significantly lower than those
before centrifugation (Figure 6). In addition, when the par-
ticle size of different concentrations of PEI-NH-SWNTs
or PEI-NH-MWNTs was compared, no significant differ-
ence was observed. These results indicate that the centri-
fugation procedure effectively reduced the particle size
and increased the homogeneity of PEI-NH-CNTs.
Zeta potential of PEI-NH-CNTs
The zeta potential of 1 mg/ml pristine or PEI-grafted
carbon nanotubes at 25°C and neutral pH wasefore and after centrifugation. The average particle diameters of 5,
fter removal of large aggregates through centrifugation was analyzed
-MWNTs were solubilized in ddH2O at a concentration of 1 mg/ml and
were centrifuged at 3,000 rpm for 30 min to remove large aggregates.
ompared to PEI-NH-SWNTs or PEI-NH-MWNTs of the same
Figure 7 Zeta potential of pristine and PEI-functionalized
carbon nanotubes. The zeta potential of 1 mg/ml pristine or PEI-
grafted carbon nanotubes at 25°C and neutral pH was determined
by dynamic light scattering. Error bars represent standard deviations
(n ≥ 3). **p < 0.01 compared to PEI-NH-SWNTs.
Figure 9 Cytotoxicity of PEI-NH-SWNTs and PEI-NH-MWNTs
compared to PEI. Human cervical cancer cells HeLa-S3 were treated
with 0 to 100 μg/ml of PEI-NH-SWNTs, PEI-NH-MWNTs, or pure PEI
for 48 h. Cell viability was determined by MTT assay and expressed
as the percentage of the optical density at 570 nm of treated cells
relative to control cells. Error bars represent standard deviations
(n ≥ 3). Statistical significance was observed at all concentrations of
PEI-NH-SWNTs, PEI-NH-MWNTs, or pure PEI compared to the control
(0 μg/ml).
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potential of pristine SWNTs and MWNTs was negative
(Figure 7), similar to those reported in the literature
[39,40]. As expected, PEI functionalization increases
the positive charge on the surface of PEI-NH-CNTs,
resulting in positive zeta potentials, which were higher in
PEI-NH-MWNTs compared to PEI-NH-SWNTs (Figure 7).
The stability of PEI-NH-CNT suspension may therefore be
maintained by electrostatic repulsion contributed by the
cationic PEI.Binding of siRNAs to PEI-NH-CNTs
The siRNA binding capacity of PEI-NH-CNTs was stud-
ied by complexing PEI-NH-CNTs to a commercially
available positive control siRNAs against the housekeep-
ing gene GAPDH, followed by electrophoretic mobilityFigure 8 Binding capacity of PEI-NH-SWNTs and PEI-NH-MWNTs towa
panel) were complexed with a commercially available positive control siRN
dehydrogenase (siGAPDH) at various mass ratios, followed by EMSA.shift assay (EMSA). The fluorescence dye SYBR Green I
intercalates with free siRNAs, resulting in a 22-bp fluor-
escent band under gel electrophoresis. Binding of PEI-
NH-CNTs to siRNAs resulted in reduced availability
of siRNAs for SYBR Green I intercalation, thus redu-
cing the fluorescence signal [18,20,21,28]. As shown in
Figure 8, there was a gradual decrease in fluorescence
intensity with increasing PEI-NH-CNT/siGAPDH
mass ratios. The migration of siGAPDH was com-
pletely inhibited when the mass ratios of PEI-
NH-SWNTs to siGAPDH and PEI-NH-MWNTs to
siGAPDH were 80:1 and 160:1, respectively (Figure 8).
These results indicate that both PEI-NH-SWNTs andrds siRNAs. PEI-NH-SWNTs (upper panel) and PEI-NH-MWNTs (lower
A against the housekeeping gene glyceraldehyde 3-phosphate
Figure 10 Relative GAPDH mRNA expression of HeLa-S3 cells
transfected with PEI-NH-CNT/siGAPDH complexes. PEI-NH-SWNTs
or PEI-NH-MWNTs were complexed with siGAPDH at mass ratios of
1:1, 10:1, and 20:1 and incubated with HeLa-S3 cells to achieve a
final siGAPDH concentration of 30 nM. After 48 h, the mRNA level of
GAPDH was analyzed by quantitative PCR. The level of GAPDH gene
suppression was quantitated to evaluate the transfection efficiency
of PEI-NH-SWNTs and PEI-NH-MWNTs. Control, HeLa-S3 cells cultured
in growth medium for 48 h; DharmaFECT, HeLa-S3 cells transfected
with siGAPDH using DharmaFECT as transfection reagent. Error bars
represent standard deviations (n ≥ 3). *p < 0.05 and **p < 0.01
compared to the control; ##p < 0.01 compared to DharmaFECT.
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plex with siRNAs.
Cytotoxicity of PEI-NH-CNTs
Human cervical cancer cells HeLa-S3 were treated
with various concentrations of PEI-NH-SWNTs or
PEI-NH-MWNTs for 48 h to examine their cytotox-
icity. Viability of HeLa-S3 cells decreased with in-
creasing concentrations of PEI-NH-CNTs (Figure 9).
The half-maximal inhibitory concentrations (IC50) of
PEI-NH-SWNTs and PEI-NH-MWNTs were 23.6 and
40.5 μg/ml, respectively. On the other hand, pure PEI
was relatively toxic, with an IC50 of 0.56 μg/ml. At a
concentration of 5 μg/ml, less than 2% of cells were vi-
able in the presence of PEI, while 70% to 80% of cells
were viable when incubated with PEI-NH-SWNTs or
PEI-NH-MWNTs (Figure 9). These results suggest
that PEI-NH-CNTs were less cytotoxic to HeLa-S3
cells compared to PEI.
Transfection of siRNAs by PEI-NH-CNTs
PEI-NH-CNTs were complexed with siGAPDH at mass
ratios of 1:1, 10:1, and 20:1 and incubated with HeLa-S3
cells to achieve a final siGAPDH concentration of 30 nM.
After 48 h, transfection efficiency of PEI-NH-CNTs
was evaluated by the mRNA level of GAPDH and was
compared with that of DharmaFECT. Transfection ofsiGAPDH with DharmaFECT resulted in more than 50%
suppression of the mRNA level of GAPDH (Figure 10).
Delivery of siGAPDH by PEI-NH-SWNTs suppressed
GAPDH mRNA expression to 18%, 50%, and 62% of un-
treated control at PEI-NH-SWNT/siGAPDH ratios of 1:1,
10:1, and 20:1, respectively. On the other hand, GAPDH
gene expression was reduced to 55% to 75% of control
when siRNAs were delivered by PEI-NH-MWNTs. How-
ever, statistical significance (p < 0.01) was only observed at
PEI-NH-MWNT/siGAPDH ratio of 10:1 (Figure 10).
Compared to DharmaFECT, PEI-NH-SWNTs gave rise to
more significant suppression of GAPDH gene expression
at a PEI-NH-SWNT/siGAPDH mass ratio of 1:1. There
was no significant difference between the transfection
efficiency of PEI-NH-SWNTs and PEI-NH-MWNTs ex-
cept when the PEI-NH-CNT/siGAPDH ratio was 1:1
(Figure 10). These results suggest that PEI-NH-SWNTs
and PEI-NH-MWNTs successfully delivered siGAPDH
to HeLa-S3 cells and that the siRNA transfection effi-
ciency of PEI-NH-SWNTs and PEI-NH-MWNTs was
comparable to that of DharmaFECT.
Discussion
Previous studies have utilized a similar direct amination
procedure as in this report to produce PEI-grafted
MWNTs. Varkouhi et al. modified MWNTs of 9.5 nm in
diameter with 25-kDa branched PEI, while Foillard et al.
synthesized PEI-functionalized MWNTs with the less
cytotoxic 600-Da branched PEI [21,28]. In both studies,
MWNTs were shortened by ultrasonication prior to PEI
functionalization. This study applied direct amination
method to both SWNTs and MWNTs but without short-
ening the carbon nanotubes. PEI functionalization in-
creased the solubility of SWNTs and MWNTs in water as
well as their binding affinity for siRNAs. We removed lar-
ger aggregates of PEI-NH-SWNTs and PEI-NH-MWNTs
by centrifugation [21,28,41] to improve their dispersity
and homogeneity (Figure 1). After centrifugation, the
particle size of PEI-NH-SWNTs and PEI-NH-MWNTs
was decreased and was less affected by concentration
(Figure 6). Surface modification of carbon nanotubes by
PEI can be observed through TEM, SEM, and FTIR
spectroscopy (Figures 2, 3, and 4) as well as the dra-
matic change in zeta potentials (Figure 7), and the
amount of grafted PEI was estimated by TGA (Figure 5).
Although both PEI-NH-SWNTs and PEI-NH-MWNTs
caused HeLa-S3 cell deaths in a dose-dependent man-
ner, they were less cytotoxic compared to pure PEI
(Figure 9). PEI-NH-SWNTs and PEI-NH-MWNTs were
capable of binding siRNAs (Figure 8) and delivering
them into HeLa-S3 cells, resulting in suppression of the
mRNA level of GAPDH to an extent similar to that of
DharmaFECT, the commercial transfection reagent for
siRNAs (Figure 10).
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MWNTs is higher than 25-kDa PEI alone in human lung
cancer cells (H1299), suggesting that MWNTs enhance
the cytotoxicity of PEI [28]. Studies on Daphnia magna
also demonstrated that PEI coating increased MWNT
toxicity, which was associated with the size of PEI coat-
ing, but not the surface charge of PEI [42]. In contrast,
our results suggest that cell viability was higher in the
presence of PEI-NH-SWNTs and PEI-NH-MWNTs
compared to pure 25-kDa PEI (Figure 9). Liu et al. ap-
plied a different approach to obtain PEI-grafted MWNTs
but reached a similar conclusion to this study by demon-
strating that, at concentrations higher than 15 μg/ml,
25-kDa PEI alone is more toxic to 293, HepG2, and
COS7 cells compared to PEI-grafted MWNTs [23]. In
addition, Wang et al. indicated that PEI-functionalized
SWNTs exhibited no significant cytotoxicity to PC-3
cells at concentrations lower than 30 μg/ml but may lead
to an increase in apoptosis [24]. In addition to concen-
tration, cytotoxicity of carbon nanotubes is correlated
with the type of functionalization [43,44], the degree of
agglomeration [32,33], as well as nanotube length [45].
Pathways leading to carbon nanotube cytotoxicity were
mainly related to DNA damage and the induction of re-
active oxygen species [46]. Nevertheless, due to the
difference in the types and synthetic procedures of PEI-
functionalized carbon nanotubes between this and previ-
ous studies and the tolerance of various cells or tissues
to the nanomaterial, the cause of carbon nanotube cyto-
toxicity remains to be investigated.
Results from EMSA showed that at PEI-NH-SWNT/
siGAPDH and PEI-NH-MWNT/siGAPDH mass ratios
of 80:1 and 160:1, respectively, siGAPDH was completely
complexed with PEI-NH-CNTs (Figure 8). However,
suppression of GAPDH mRNA expression was observed
at relatively lower mass ratios of 1:1 to 1:20 (Figure 10).
Such discrepancy in the effective ratios of functionalized
carbon nanotubes to siRNAs or DNAs in EMSA and in
gene delivery is also presented in previous studies
[18,20,23]. Amino-functionalized MWNTs (MWNT-NH3
+)
is unable to completely retard the migration of siRNAs in
EMSA at a MWNT-NH3
+/siRNA mass ratio of 80:1, but
the cationic MWNTs successfully delayed tumor growth in
animal models when complexed with siRNAs at a mass ra-
tio of 8:1 [20]. These findings implicate that complete
binding of siRNAs by PEI-NH-CNTs may not be necessary
for a successful intracellular siRNA delivery. Increasing the
amount of PEI-NH-CNTs relative to siRNAs may provide
more stable complexes of PEI-NH-CNT/siRNA but may
possibly hinder the dissociation of siRNAs from PEI-NH-
CNTs once the complex enters the cytosol.
Carbon nanotubes are considered an efficient carrier
for nonviral gene delivery. Compared to viral vectors,
nonviral transfection reagents eliminate the possibility ofcarcinogenesis and severe immune response caused by
viral vectors and provide a safer alternative for the clin-
ical application of gene therapy [47]. However, the effi-
ciency of nonviral transfection is relatively low
compared to viral transfection. We showed that the
siRNA transfection efficiency of both PEI-NH-SWNTs
and PEI-NH-MWNTs was comparable to the commer-
cially available DharmaFECT reagent (Figure 10). A
similar comparison of transfection efficiency with an-
other common transfection reagent was reported on
MWNTs functionalized with 600-Da PEI [21]. Never-
theless, Varkouhi et al. compared the transfection
efficiency of PEI-functionalized MWNTs with
Lipofectamine but found that PEI-functionalized
MWNTs were less effective in siRNA delivery [28]. Fur-
ther studies on in vivo siRNA transfection by PEI-
functionalized carbon nanotubes may be necessary to
elucidate their effectiveness in gene delivery.
Conclusions
This study demonstrated that effective carrier for siRNAs
can be achieved through direct amination of SWNTs and
MWNTs with 25-kDa branched PEI. The resulting PEI-NH
-SWNTs and PEI-NH-MWNTs complexed with siRNAs,
successfully delivered siRNAs into HeLa-S3 cells, and
exhibited transfection efficiency comparable to commercial
reagents. Modification of the PEI functionalization proced-
ure may be required to reduce the cytotoxicity of PEI-
NH-SWNTs and PEI-NH-MWNTs. Further investigation
on the in vivo transfection efficiency of PEI-NH-SWNTs
and PEI-NH-MWNTs is necessary to enhance their thera-
peutic potential in gene therapy.
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